Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TENORETIC 100 | Almatica Pharma | N-018760 RX | 1984-06-08 | 1 products, RLD, RS |
TENORETIC 50 | Almatica Pharma | N-018760 RX | 1984-06-08 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
THALITONE | Casper Pharma | N-019574 RX | 1988-12-20 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COMBIPRES | Boehringer Ingelheim | N-017503 DISCN | 1982-01-01 | 3 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
atenolol and chlorthalidone | ANDA | 2024-01-16 |
chlorthalidone | ANDA | 2024-01-18 |
edarbyclor | New Drug Application | 2024-02-01 |
tenoretic | New Drug Application | 2023-08-31 |
thalitone | New Drug Application | 2019-12-30 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 7 | 6 | 25 | 15 | 12 | 65 |
Essential hypertension | D000075222 | — | I10 | — | — | 5 | 2 | 3 | 10 |
Chronic renal insufficiency | D051436 | — | N18 | — | 2 | — | 4 | 1 | 7 |
Heart failure | D006333 | HP_0001635 | I50 | — | 1 | 2 | 2 | — | 4 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | 1 | 1 | 2 |
Left ventricular hypertrophy | D017379 | EFO_0003896 | — | — | — | — | 2 | — | 2 |
Cardio-renal syndrome | D059347 | — | — | — | 1 | — | 1 | — | 2 |
Aortic valve stenosis | D001024 | HP_0001650 | — | — | — | — | 1 | — | 1 |
Aortic valve insufficiency | D001022 | EFO_0007148 | — | — | — | — | 1 | — | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 2 | 8 | — | 1 | 11 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 2 | 5 | — | 1 | 8 |
Coronary disease | D003327 | — | — | — | — | 2 | — | 2 | 4 |
Healthy volunteers/patients | — | — | — | 2 | — | 1 | — | — | 3 |
Vascular diseases | D014652 | EFO_0004264 | I77 | — | 2 | 1 | — | — | 3 |
Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | 2 | — | — | 2 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | 2 | — | — | 2 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | 1 | — | 1 | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | — | 1 |
Hypercalciuria | D053565 | HP_0002150 | R82.994 | — | 1 | — | — | — | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ambulatory blood pressure monitoring | D018660 | — | — | — | — | — | — | 1 | 1 |
Vascular stiffness | D059289 | — | — | — | — | — | — | 1 | 1 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 1 | 1 |
Kidney calculi | D007669 | EFO_0004253 | N20 | — | — | — | — | 1 | 1 |
Breast feeding | D001942 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Chlorthalidone |
INN | chlortalidone |
Description | Chlorthalidone is a sulfonamide, a member of isoindoles and a member of monochlorobenzenes. |
Classification | Small molecule |
Drug class | Thiazide-like diuretic |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl |
PDB | — |
CAS-ID | 77-36-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1055 |
ChEBI ID | 3654 |
PubChem CID | 2732 |
DrugBank | DB00310 |
UNII ID | Q0MQD1073Q (ChemIDplus, GSRS) |